Abstract
Background: Most patients with pancreatic cancer suffer a relapse, which occurs either locally or systemically in the sense of liver and the lung metastases. Surgery for pancreatic cancer has become more radical due to the increased use of multimodal treatment concepts;however, the role of surgery in cases of recurrence remains controversial. Objective: This review summarizes the surgical treatment options for isolated local recurrence and metachronous oligometastatic pancreatic cancer. Material and methods: A selective literature search was carried out and the current evidence for surgical treatment is summarized. Results: There are currently no randomized studies on surgery for metastatic pancreatic cancer. Currently available data, however, show that after surgery long-term survival of up to 32-47 months after metastasectomy can be achieved, especially in patients with local recurrence or isolated pulmonary metastases with low morbidity and mortality. Individualized treatment concepts including surgical resection after initial systemic therapy seem promising even for liver metastases. The greatest survival benefits are consistently shown for all localizations in patients with a long as possible disease-free interval after the first operation. Conclusion: The treatment of isolated local recurrence or metachronous oligometastatic pancreatic cancer is an interdisciplinary challenge that should be performed in specialized pancreatic treatment centers only. Surgical resection embedded in a multimodal treatment concept can be meaningful in selected cases.
| Dokumententyp: | Zeitschriftenartikel |
|---|---|
| Fakultät: | Medizin |
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| ISSN: | 0009-4722 |
| Sprache: | Deutsch |
| Dokumenten ID: | 85061 |
| Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022, 09:13 |
| Letzte Änderungen: | 25. Jan. 2022, 09:13 |
- Dokument bearbeiten
